This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue Rs 15.16 crore vs Rs 13.92 crore year-ago; PAT Rs 0.13 crore
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026, approved by the Board: revenue Rs 1,516.18 lakh versus Rs 1,392.43 lakh a year earlier; PAT Rs 13.09 lakh versus Rs 16.66 lakh. Revenue rose 8.9%, but PAT fell 21.4%; the operating margin before interest, tax, depreciation and amortisation narrowed to 1.7% from 4.3%. Standalone half-year revenue was Rs 3,009.70 lakh and PAT Rs 36.32 lakh, versus Rs 2,444.96 lakh and Rs 27.19 lakh.
Lower PAT and a 2.5 percentage point operating margin contraction signal profitability pressure, despite higher revenue.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹14.94 Cr | ₹13.92 Cr | +7.3% |
| Operating profit | ₹0.16 Cr | ₹0.08 Cr | +104.2% |
| Profit after tax | ₹0.23 Cr | ₹0.17 Cr | +39.5% |
| EBITDA margin | 3.3% | 4.3% | −1.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.